Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — April 2016

Planlagt Fastgjort Låst Flyttet Genmab
2.7k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • O Offline
    O Offline
    OHW
    wrote on sidst redigeret af
    #2631

    hmmm...det ser godt nok ikke ud til, at noget vil trække os i ATH i dag..

    1 Reply Last reply
    0
    • royalR Offline
      royalR Offline
      royal
      wrote on sidst redigeret af
      #2632

      Tak Bulder.

      1 Reply Last reply
      0
      • dingleberryD Offline
        dingleberryD Offline
        dingleberry
        wrote on sidst redigeret af
        #2633

        wauw - check lige IMGN her i åbningen!

        1 Reply Last reply
        0
        • dingleberryD Offline
          dingleberryD Offline
          dingleberry
          wrote on sidst redigeret af
          #2634

          og store prygl til GILD som forventet

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Sukkeralf
            wrote on sidst redigeret af
            #2635

            IMGN av - hvad sker der?

            1 Reply Last reply
            0
            • M Offline
              M Offline
              MUFC_Oberanven
              wrote on sidst redigeret af
              #2636

              ImmunoGen Reports Wider Q3 Loss Vs. Street, Misses on Revenue; Lowers FY16 Revenue Outlook Below Forecasts<IMGN.OQ> - MT Newswires

              29-Apr-2016 13:15:18

              07:09 AM EDT, 04/29/2016 (MT Newswires) -- ImmunoGen (IMGN) reported Friday that
              for Q3 ended March 31, its loss was wider than expected, and revenue fell short
              of analysts' estimates; it also lowered its revenue guidance for fiscal 2016
              below Street forecasts.

              The clinical-stage biotechnology company posted Q3 net loss of $31.9 million, or
              $0

              1 Reply Last reply
              0
              • dingleberryD Offline
                dingleberryD Offline
                dingleberry
                wrote on sidst redigeret af
                #2637

                det kan vist ikke betale sig at skuffe forventninger i det her marked....

                1 Reply Last reply
                0
                • dingleberryD Offline
                  dingleberryD Offline
                  dingleberry
                  wrote on sidst redigeret af
                  #2638

                  IMGN justerede guidance - 2016 guidance for its net loss is now expected to be between $135 million and $140 million, versus previous estimate of $120 million and $125 million

                  1 Reply Last reply
                  0
                  • dingleberryD Offline
                    dingleberryD Offline
                    dingleberry
                    wrote on sidst redigeret af
                    #2639

                    så ikke noget med klinikken

                    1 Reply Last reply
                    0
                    • dingleberryD Offline
                      dingleberryD Offline
                      dingleberry
                      wrote on sidst redigeret af
                      #2640

                      hold da helt kæft, hvor er US sur!

                      1 Reply Last reply
                      0
                      • A Offline
                        A Offline
                        andreas961
                        wrote on sidst redigeret af
                        #2641

                        kan det anbefales at købe genmab aktier nu?

                        1 Reply Last reply
                        0
                        • BulderB Offline
                          BulderB Offline
                          Bulder
                          wrote on sidst redigeret af
                          #2642

                          tak, Jedi

                          1 Reply Last reply
                          0
                          • J Offline
                            J Offline
                            Jedi
                            wrote on sidst redigeret af
                            #2643

                            hmm, så overhalede IMGN da lige Vitae som min dårligst performende investering - godt at det kun er små positioner..

                            1 Reply Last reply
                            0
                            • dingleberryD Offline
                              dingleberryD Offline
                              dingleberry
                              wrote on sidst redigeret af
                              #2644

                              hmm - US minder mest om en basejumper, der har glemt dragten

                              1 Reply Last reply
                              0
                              • Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktør
                                wrote on sidst redigeret af
                                #2645

                                Genmab er stadig det store hit hos Investtec. http://penge.borsen.dk/artikel/1/323780/teknisk_analyse_potentiale_paa_24_pct_i_neutralt_marked.html

                                1 Reply Last reply
                                0
                                • Legolas23L Offline
                                  Legolas23L Offline
                                  Legolas23
                                  wrote on sidst redigeret af
                                  #2646

                                  Artiklen kan ikke breakes af dødlige. Kan du komme op med sessensen ?

                                  1 Reply Last reply
                                  0
                                  • J Offline
                                    J Offline
                                    jkj
                                    wrote on sidst redigeret af
                                    #2647

                                    hvis man kan absorber markeds voaliteten, så er genmab absolut købs anfefalet pt. i det at vi nyheds mæssigt står foran 3 meget stærke måneder

                                    1 Reply Last reply
                                    0
                                    • J Offline
                                      J Offline
                                      jkj
                                      wrote on sidst redigeret af
                                      #2648

                                      mit gæt er at vi når kurs 1100-1150 inden ASCO og 1200 efter.

                                      1 Reply Last reply
                                      0
                                      • J Offline
                                        J Offline
                                        jkj
                                        wrote on sidst redigeret af
                                        #2649

                                        på mb er de forundret over at castor ikke har fået mere bevågenhed. For de informationer som genmab er kommet med, er uden fortilfældehttps://www.google.dk/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahUKEwjf0MLB37TMAhXrE5oKHWTPBzMQFggdMAA&url=http%3A%2F%2Fwww.myelomabeacon.com%2Fdeutsch%2F2016%2F04%2F29%2Fmyeloma-morning-darzalex-castor-treanda-stammzelltransplantation%2F&usg=AFQjCNGaKsEwCGz8gH9xce5L1wIDLGOCBw&bvm=bv.121070826,d.bGs

                                        1 Reply Last reply
                                        0
                                        • MrEbbeM Offline
                                          MrEbbeM Offline
                                          MrEbbe
                                          wrote on sidst redigeret af
                                          #2650

                                          Hvem/hvad er MB?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger